CDH1 and cancer: For example, exogenous expression of miR-200 in cancer cell lines promotes the expression of E-cadherin while inhibition of miR-200 promotes the acquisition of a mesenchymal phenotype with reduced E-cadherin expression and increased vimentin expression [64].